4//SEC Filing
Exter Neil 4
Accession 0000899243-22-022011
CIK 0001628171other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 7:03 PM ET
Size
8.6 KB
Accession
0000899243-22-022011
Insider Transaction Report
Form 4
Exter Neil
Director
Transactions
- Sale
Common Stock
2022-06-08−0→ 0 total(indirect: See footnote)
Holdings
- 23,615
Common Stock
- 19,998(indirect: See footnote)
Common Stock
- 0(indirect: See footnotes)
Common Stock
Footnotes (5)
- [F1]On June 8, 2022, Third Rock Ventures III, L.P. ("TRV III") sold 419,901 shares of Common Stock of the Issuer in multiple transactions at prices ranging from $20.25 to $20.41, inclusive, at a weighted average price per share of $20.25. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- [F2]After the above transaction, TRV III owned 5,104,130 shares of Common Stock of the Issuer.
- [F3]The Reporting Person is a partner of each of TRV GP III, L.P. and Third Rock Ventures GP IV, L.P. which is the general partner of each of TRV III and Third Rock Ventures IV, L.P. ("TRV IV" and collectively with TRV III, "the Funds"), respectively. The Reporting Person disclaims beneficial ownership over the shares held by the Funds, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
- [F4]TRV IV directly holds 1,419,900 shares of Common Stock of the Issuer.
- [F5]The shares are directly held in certain estate-planning trusts over which the Reporting Person may have voting and dispositive power. The Reporting Person disclaims beneficial ownership over the shares held by such trusts except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001620014
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 7:03 PM ET
- Size
- 8.6 KB